We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-6.95%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.11B
AUM Growth
-$244M
(-18%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-11.97%
Top 10 Holdings %
Top 10 Hldgs %
3.48%
Holding
2,176
New
618
Increased
465
Reduced
510
Closed
580
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$4.82M |
| 2 |
Blackstone
BX
|
+$4.54M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$3.82M |
| 4 |
Cal-Maine
CALM
|
+$3.17M |
| 5 |
Ziff Davis
ZD
|
+$3.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$97.2M |
| 2 |
NVIDIA
NVDA
|
+$7.97M |
| 3 |
Microsoft
MSFT
|
+$7.34M |
| 4 |
Amazon
AMZN
|
+$7.07M |
| 5 |
Costco
COST
|
+$6.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.36% |
| 2 | Financials | 14.89% |
| 3 | Technology | 13.64% |
| 4 | Consumer Discretionary | 13.03% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LONA
1576
LeonaBio Inc
LONA
$72.1M
| $25K | ﹤0.01% |
8,823
-20,833
| -70% | -$92.3K |
|
1577
SELLAS Life Sciences
SLS
$2.36B
| $25K | ﹤0.01% |
+22,727
| New | +$27K |
|
1578
Mammoth Energy Services
TUSK
$163M
| $25K | ﹤0.01% |
+12,029
| New | +$32.1K |
|
1579
Wrap Technologies
WRAP
$104M
| $25K | ﹤0.01% |
14,545
-72,915
| -83% | -$151K |
|
1580
Commercial Vehicle Group
CVGI
$147M
| $24K | ﹤0.01% |
20,478
+8,075
| +65% | +$15.6K |
|
1581
Compass Therapeutics
CMPX
$387M
| $23K | ﹤0.01% |
+12,187
| New | +$32.4K |
|
1582
Annexon
ANNX
$886M
| $22K | ﹤0.01% |
+11,425
| New | +$38K |
|
1583
Biodesix
BDSX
$248M
| $21K | ﹤0.01% |
+1,667
| New | +$32K |
|
|
ETWO
1584
DELISTED
E2open Parent Holdings
ETWO
| $21K | ﹤0.01% |
10,594
-81,589
| -89% | -$202K |
|
1585
ProQR Therapeutics
PRQR
$265M
| $20K | ﹤0.01% |
+14,683
| New | +$31.3K |
|
1586
Chegg
CHGG
$102M
| $18K | ﹤0.01% |
+27,641
| New | +$34.2K |
|
|
GGRP
1587
Glimpse Group
GGRP
$18.7M
| $17K | ﹤0.01% |
+14,956
| New | +$24.6K |
|
1588
Caribou Biosciences
CRBU
$164M
| $16K | ﹤0.01% |
+17,605
| New | +$22.9K |
|
|
AFMD
1589
DELISTED
Affimed
AFMD
| $11K | ﹤0.01% |
+15,895
| New | +$16.2K |
|
1590
GrafTech
EAF
$212M
| $11K | ﹤0.01% |
+1,216
| New | +$15.8K |
|
1591
Nautilus Biotechnolgy
NAUT
$115M
| $11K | ﹤0.01% |
+12,512
| New | +$18.6K |
|
1592
Cognition Therapeutics
CGTX
$96.7M
| $9K | ﹤0.01% |
+22,354
| New | +$13.1K |
|
1593
Vor Biopharma
VOR
$1.28B
| $9K | ﹤0.01% |
+593
| New | +$14.2K |
|
1594
Coherus Oncology
CHRS
$196M
| $8K | ﹤0.01% |
10,153
-112,869
| -92% | -$130K |
|
1595
Veru
VERU
$37.4M
| $7K | ﹤0.01% |
+1,498
| New | +$9.29K |
|
1596
cbdMD
YCBD
$5.93M
| $7K | ﹤0.01% |
+3,970
| New | +$13.9K |
|
1597
American Airlines Group
AAL
$10.6B
| – | – |
-40,339
| Closed | -$703K |
|
1598
Applied Optoelectronics
AAOI
$11.5B
| – | – |
-22,890
| Closed | -$844K |
|
1599
Adicet Bio
ACET
$74.7M
| – | – |
-1,048
| Closed | -$16K |
|
1600
Accenture
ACN
$108B
| – | – |
-7,195
| Closed | -$2.53M |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2025 Portfolio in Review
As of Q1 2025, GSA Capital Partners held 2,176 positions worth $1.11B, down 18% from $1.35B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
GSA Capital Partners withdrew a net $132M in Q1 2025, closing 580 positions and reducing 510 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $97.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
Against the trend, GSA Capital Partners opened a new position in CSX Corp worth $4.46M.
- GSA Capital Partners's largest Q1 2025 buy was CSX Corp: 151,729 shares worth $4.46M.
- GSA Capital Partners added most to Blackstone in Q1 2025, an estimated $4.54M increase.
- GSA Capital Partners's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $7.97M.
- GSA Capital Partners fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $97.2M.
- GSA Capital Partners's ten largest holdings make up 3.5% of its $1.11B portfolio in Q1 2025.
- GSA Capital Partners opened 618 new positions and closed 580 in Q1 2025.
- GSA Capital Partners's portfolio value fell 18% quarter-over-quarter to $1.11B.
Based on GSA Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.